Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Kaplowitz

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Pharmacogenetics and Genomics|March 18, 2011
Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumabJanet S Lee, Jianmei Wang, Mitchell Martin, et al.
Free Radical Biology & Medicine|November 22, 2016
Mitochondrial remodeling in the liver following chronic alcohol feeding to ratsDerick Han, Heather S Johnson, Madhuri P Rao, et al.
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Gastroenterology|July 23, 2008
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidatesMichael B Fallon, Michael J Krowka, Robert S Brown, et al.
Drug Safety|July 20, 2015
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B Watkins, James H Lewis, Neil Kaplowitz, et al.
The Journal of Biological Chemistry|October 23, 2012
Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterationsDerick Han, Maria D Ybanez, Heather S Johnson, et al.
Acta Pharmaceutica Sinica. B|February 7, 2022
The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury <i>via</i> mitigation of macrophage pro-inflammatory activity in miceRui Li, Li Xie, Lei Li, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Death and liver transplantation within 2 years of onset of drug-induced liver injuryPaul H Hayashi, Don C Rockey, Robert J Fontana, et al.
The American Journal of Clinical Nutrition|July 10, 2007
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposiumVishnudutt Purohit, Manal F Abdelmalek, Shirish Barve, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver ToxicityIvan Rusyn, Xabier Arzuaga, Russell C Cattley, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Pharmacogenetics and Genomics|March 18, 2011
Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumabJanet S Lee, Jianmei Wang, Mitchell Martin, et al.
Free Radical Biology & Medicine|November 22, 2016
Mitochondrial remodeling in the liver following chronic alcohol feeding to ratsDerick Han, Heather S Johnson, Madhuri P Rao, et al.
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Gastroenterology|July 23, 2008
Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidatesMichael B Fallon, Michael J Krowka, Robert S Brown, et al.
Drug Safety|July 20, 2015
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B Watkins, James H Lewis, Neil Kaplowitz, et al.
The Journal of Biological Chemistry|October 23, 2012
Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterationsDerick Han, Maria D Ybanez, Heather S Johnson, et al.
Acta Pharmaceutica Sinica. B|February 7, 2022
The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury <i>via</i> mitigation of macrophage pro-inflammatory activity in miceRui Li, Li Xie, Lei Li, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Death and liver transplantation within 2 years of onset of drug-induced liver injuryPaul H Hayashi, Don C Rockey, Robert J Fontana, et al.
The American Journal of Clinical Nutrition|July 10, 2007
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposiumVishnudutt Purohit, Manal F Abdelmalek, Shirish Barve, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver ToxicityIvan Rusyn, Xabier Arzuaga, Russell C Cattley, et al.
Pageof 16